Health
Fluvoxamine may prevent serious illness in COVID-19 patients – China.org.cn
CHICAGO, Nov. 13 (Xinhua) — Researchers at Washington University School of Medicine in St. Louis have found in a preliminary study that the drug fluvoxamine seems to prevent some of the most serious complications of COVID-19 patients and make hospitalization and the need for supplemental oxygen less likely.
In an innovative twist to research during the pandemic, the study, involving 152 patients infected with SAR-CoV-2, the virus that causes COVID-19, was conducted remotely. When a symptomatic…
-
General2 hours agoFerries and celebrities as pollies dash to win the west
-
Noosa News22 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
General23 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Noosa News23 hours agoAppeal heard against sentences of teens who attacked Toutai Kefu and family in their Brisbane home